Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04062708Phase 2Active Not Recruiting
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
StudychairStart date: 2021-03-10

Research Network

Collaboration Network

12 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Diego

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Crystal Denlinger, MD

Fox Chase Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Sanjiv Gambhir, MD, PhD

Stanford University

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Moderately Similar
6 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Agustin Garcia

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Anthony Shields

Barbara Ann Karmanos Cancer Institute

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Kristin Higgins, MD

Emory University

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Alex Adjei

Roswell Park Cancer Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Virginia Sun

City of Hope Medical Center

Moderately Similar
10 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Voichita Bar-Ad, MD

Thomas Jefferson University

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Elisabeth Weiss, MD

Massey Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04062708Phase 2StudyChair

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Active Not Recruiting

All 1 trials loaded